DUBLIN, Feb. 26,
2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS)
announced today that management will participate in webcast
fireside chats at two upcoming investor conferences.
TD Cowen 45th Annual Health Care
Conference
Date/Time: Wednesday, March 5, 2025 at 9:50 a.m. ET (2:50 p.m.
GMT)
Leerink Partners Global Healthcare Conference
2025
Date/Time: Wednesday, March 12, 2025 at 11:20 a.m. ET (3:20 p.m.
GMT)
The live webcasts may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and
bipolar I disorder, and a pipeline of clinical and preclinical
candidates in development for neurological disorders, including
narcolepsy and idiopathic hypersomnia. Headquartered
in Ireland, Alkermes
also has a corporate office and research and development
center in Massachusetts and a
manufacturing facility in Ohio.
For more information, please visit Alkermes' website
at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-upcoming-investor-conferences-302386193.html
SOURCE Alkermes plc
